Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of MC2-01 Cream vs Comparator in Extensive Psoriasis Vulgaris
NCT03462927Phase 2Completed
- Sponsor
- MC2 Therapeutics
- Start
- Feb 2018
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcipotriol, betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV), sponsored by MC2 Therapeutics. Started Feb 2018; status: completed.
02
Drugs
calcipotriolbetamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT03462927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462927.